BAX - Baxter International Inc Stock Price, Fair Value and News

$33.45+0.46 (+1.39%)

Delayed as of 22 Nov 2024, 11:39 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BAX Price Action

Last 7 days

4.1%

Last 30 days

-9.8%

Last 90 days

-12.1%

Trailing 12 Months

-8.0%

BAX RSI Chart

BAX Valuation

Market Cap

16.8B

Price/Earnings (Trailing)

155.97

Price/Sales (Trailing)

1.2

EV/EBITDA

20.82

Price/Free Cashflow

15.86

BAX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BAX Fundamentals

BAX Revenue

Revenue (TTM)

14.0B

Rev. Growth (Yr)

-27.21%

Rev. Growth (Qtr)

-29.2%

BAX Earnings

Earnings (TTM)

108.0M

Earnings Growth (Yr)

-94.42%

Earnings Growth (Qtr)

144.59%

BAX Profitability

EBT Margin

1.19%

Return on Equity

1.36%

Return on Assets

0.4%

Free Cashflow Yield

6.3%

BAX Investor Care

Dividend Yield

2.36%

Dividend/Share (TTM)

0.8

Shares Dilution (1Y)

0.64%

Diluted EPS (TTM)

0.2

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	14.9B	15.0B	14.0B	0
2023	14.5B	14.6B	14.7B	14.8B
2022	12.8B	13.3B	13.6B	14.5B
2021	11.8B	12.2B	12.5B	12.1B
2020	11.5B	11.4B	11.5B	11.7B
2019	11.0B	11.1B	11.2B	11.4B
2018	10.8B	11.0B	11.0B	11.1B
2017	10.3B	10.3B	10.4B	10.6B
2016	9.9B	10.1B	10.1B	10.2B
2015	10.6B	10.4B	10.2B	10.0B
2014	14.1B	13.3B	12.3B	10.7B
2013	14.2B	14.2B	14.4B	15.0B
2012	14.0B	14.0B	14.0B	14.2B
2011	13.2B	13.5B	13.8B	13.9B
2010	12.7B	12.7B	12.8B	12.8B
2009	0	0	0	12.6B

Get all data in R, Python etc through our Historical Stock Data APIs

About Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.

CEO	Mr. Jose E. Almeida
WEBSITE	baxter.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	60000

Baxter International Inc Frequently Asked Questions

What is the ticker symbol for Baxter International Inc? What does BAX stand for in stocks?

BAX is the stock ticker symbol of Baxter International Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Baxter International Inc (BAX)?

As of Thu Nov 21 2024, market cap of Baxter International Inc is 16.84 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BAX stock?

You can check BAX's fair value in chart for subscribers.

Is Baxter International Inc a good stock to buy?

The fair value guage provides a quick view whether BAX is over valued or under valued. Whether Baxter International Inc is cheap or expensive depends on the assumptions which impact Baxter International Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BAX.

What is Baxter International Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, BAX's PE ratio (Price to Earnings) is 155.97 and Price to Sales (PS) ratio is 1.2. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BAX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Baxter International Inc's stock?

In the past 10 years, Baxter International Inc has provided -0.018 (multiply by 100 for percentage) rate of return.